« Return to News | Ethics/Regulatory | CROs/Service Providers

CWWeekly January 22nd 2008 Issue

Friday, January 25, 2008 03:31 PM

Top News

U.S. Supreme Court Will Not Hear Abigail Alliance v. Eschenbach

The Abigail Alliance’s petition for a writ of certiorari in The Supreme Court of the United States was denied on January 14. The question presented was “whether terminally ill patients who lack alternative treatment options have a constitutional right to purchase unapproved investigational drugs that have not been shown to be safe or effective and that have not been authorized for treatment uses by the Food and Drug Administration.”

Cetero Research Adds Metabolic Expertise with DGD Acquisition

Cary, N.C.-based early stage contract research organization (CRO) Cetero Research broadened its range of therapeutic area research with the acquisition of San Antonio, Texas-based CRO, DGD Research. Financial details were not disclosed. The acquired CRO, which conducts studies in both early- and late-stage trials, was formerly known as Diabetes & Glandular Disease Research Associates.

Other breaking news... 

  • Kendle expands phase I, Asia-Pacific business...
  • Clinical Ink launches web initiative...

Company Profile: An interview with Michael O’Connell, director of Life Science Solutions Group, Insightful, Life Sciences Division

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.